Capital Research Global Investors
Source: SEC Form 13F · as of Mar 2026Capital Research Global Investors holds 13 biotech & pharma companies tracked by BioSniper, totaling $7.71B in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$7.71B
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 27,127,533 | $3.78B |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 9,471,181 | $3.13B |
| BMRNBIOMARIN PHARMACEUTICAL INC | 3,491,386 | $197.2M |
| ADMAADMA BIOLOGICS, INC. | 11,191,116 | $100.8M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 1,115,460 | $97.0M |
| SNYSanofi | 1,661,837 | $80.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 101,891 | $78.7M |
| BBIOBridgeBio Pharma, Inc. | 763,702 | $56.7M |
| PCVXVaxcyte, Inc. | 912,688 | $53.0M |
| CYTKCYTOKINETICS INC | 770,999 | $50.8M |
| DNLIDenali Therapeutics Inc. | 2,514,588 | $48.3M |
| IONSIONIS PHARMACEUTICALS INC | 323,015 | $24.3M |
| BHVNBiohaven Ltd. | 1,332,792 | $11.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.